Search Results

You are looking at 1 - 2 of 2 items for :

  • "responsive neurostimulation" x
  • All content x
  • By Author: Chen, Tsinsue x
Clear All
Free access

James J. Zhou, Tsinsue Chen, S. Harrison Farber, Andrew G. Shetter, and Francisco A. Ponce

control, and no changes in neuropsychological testing were noted after DBS therapy. One patient developed an asymptomatic intracranial hemorrhage diagnosed incidentally on imaging, 1 patient required cable revision because of hardware failure, and 1 patient developed a wound infection requiring system explantation; otherwise, no serious adverse events were reported. Discussion The role of neuromodulation for the treatment of epilepsy has expanded over the past decade. Vagal nerve stimulation and responsive neurostimulation are approved therapies for epilepsy in the US

Free access

Alexander C. Whiting, Tsinsue Chen, Kyle I. Swanson, Corey T. Walker, Jakub Godzik, Joshua S. Catapano, and Kris A. Smith

. Patients who were deemed skip patients often demonstrated convincing MTS on MRI, with 85.4% (76/89) of the patients who avoided invasive monitoring demonstrating MTS on MRI. Because there are significant differences in seizure outcomes between patients with evidence of MTS on MRI versus those without, in the future, it may be necessary to consider nonsurgical options more readily for patients without MTS. Multiple nondestructive options, such as responsive neurostimulation or deep brain stimulation, are now approved and used throughout the country. It may be worthwhile